Rafcon Oral Suspension
(500 mg+267 mg+160 mg)/10 ml
200 ml bottle:
৳ 250.00
Indications
Rafcon is indicated in-
- Gastric reflux
- Heartburn
- Indigestion
- Flatulence associated with gastric reflux
- Heartburn of pregnancy
- All cases of epigastric and retrosternal distress where the underlying cause is gastric reflux.
Pharmacology
This is the combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate). The suspension work in two ways-
- Neutralizing excess stomach acid to relieve the pain & discomfort
- Forming a protective barrier over the stomach contents to soothe the burning pain in your chest.
Dosage & Administration
For oral suspension:
Hepatic Impairment: No dose modification necessary.
Renal Insufficiency: Caution if highly restricted salt diet is necessary.
- Adult and children over 12 years:10-20 mL after meals and at bedtime, up to four times a day.
- Children 6 to 12 years: 5-10 mL after meals and at bedtime, up to four times a day.
- Children under 6 years: Not recommended.
- Elderly: No dose modifications necessary.
- Adults and children 12 years and over: Take two to four tablets after meals and at bedtime, up to four times a day.
- Children under 12 years: Tablets should be given only on medical advice.
Hepatic Impairment: No dose modification necessary.
Renal Insufficiency: Caution if highly restricted salt diet is necessary.
Interaction
A time-interval of 2 hours should be considered between Rafcon intake and the administration of other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers (Atenolol, Metoprolol, Propranolol), Glucocorticoid, Chloroquine and Biphosphonates (diphosphonates) and Estramustine.
Contraindications
This product is contraindicated in patients with known or suspected hypersensitivity to the active ingredients or to any of the excipients.
Side Effects
In addition to the desired effect of the drug, some side effects may appear such as: constipation, flatulence, stomach cramp or belching. In these cases consult a physician. If too big dose has been taken, there might appear a sensation of swelling. In this case, it is advisable to consult a physician.
Pregnancy & Lactation
Pregnancy: Clinical studies in more than 500 pregnant women, as well as a large amount of data from post-marketing experience, indicate no malformative nor feto/neonatal toxicity of the active ingredients. This drug can be used during pregnancy, if clinically needed.
Breastfeeding: No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.
Fertility: Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.
Breastfeeding: No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.
Fertility: Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.
Precautions & Warnings
Each 20 ml of dose has a sodium content of 254.5 mg (11.06 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment.
Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium containing renal calculi.
Treatment of children younger than 12 years of age is not generally recommended, except on medical advice.
Rafcon is considered high in sodium. This should be taken into account when a highly restricted salt diet is recommended, e.g., in some cases of congestive cardiac failure and renal impairment. Each tablet contains 75 mg of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Due to its aspartame content Rafcon should not be given to patients with phenylketonuria. If symptoms persist, or treatment is required for more than 7 days continuously, medical advice should be sought. Taking Rafcon can mask the symptoms of other more serious, underlying medical conditions. It should not be used in patients with impaired renal function/insufficiency and with hypophosphatemia. This may cause allergic reactions.
Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium containing renal calculi.
Treatment of children younger than 12 years of age is not generally recommended, except on medical advice.
Rafcon is considered high in sodium. This should be taken into account when a highly restricted salt diet is recommended, e.g., in some cases of congestive cardiac failure and renal impairment. Each tablet contains 75 mg of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Due to its aspartame content Rafcon should not be given to patients with phenylketonuria. If symptoms persist, or treatment is required for more than 7 days continuously, medical advice should be sought. Taking Rafcon can mask the symptoms of other more serious, underlying medical conditions. It should not be used in patients with impaired renal function/insufficiency and with hypophosphatemia. This may cause allergic reactions.
Overdose Effects
In the event of over dosage symptomatic treatment should be given. The patient may notice abdominal distension.
Therapeutic Class
Antacids
Storage Conditions
Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.
Common Questions about Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension
What is Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension, and how does it work?
Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension is a medication used to treat symptoms of gastroesophageal reflux, including acid regurgitation, heartburn, and indigestion. It works by forming a thick protective layer, or "raft," on top of the stomach contents when it comes into contact with stomach acid. This raft acts as a physical barrier, preventing stomach acid from rising into the esophagus, which can cause irritation and discomfort. By keeping the acid and stomach contents in place, Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension helps alleviate symptoms associated with acid reflux and provides relief to patients experiencing digestive discomfort.
What are the indications for using Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension?
Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension is primarily indicated for the treatment of symptoms caused by gastroesophageal reflux disease (GERD), such as acid regurgitation, heartburn, and indigestion. It is particularly useful for patients who experience these symptoms after meals, during pregnancy, or due to reflux esophagitis. This medication provides relief by neutralizing stomach acid and preventing it from irritating the esophagus. Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension is also beneficial for individuals suffering from acid-related digestive issues, helping to improve their overall comfort and well-being.
How should Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension be taken, and what is the recommended dosage?
The recommended dosage of Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension varies based on age. For adults and children over 12 years, the advised dose is 10-20 mL, four times daily, taken after meals and at bedtime. For children under 12 years, the medication should only be used upon medical advice. Patients should follow the prescribed dosage and avoid exceeding the recommended amount without consulting a healthcare professional. It is essential to take the medication as directed to achieve the best results and ensure effective relief from symptoms.
Are there any contraindications or precautions to consider before taking Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension?
Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension is contraindicated in patients with known hypersensitivity to its active ingredients, including Sodium Alginate, Sodium Bicarbonate, and Calcium Carbonate. Additionally, this medication should be used with caution in individuals with renal impairment or congestive cardiac failure, as it may affect electrolyte balance. Patients with pre-existing medical conditions should consult their healthcare provider before using Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension. It is always recommended to inform the doctor about any ongoing medications to prevent potential drug interactions.
What are the possible side effects of Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension?
While Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension is generally well-tolerated, some patients may experience mild side effects. These can include skin rashes and breathing difficulties in individuals who are sensitive to its components. If any allergic reactions occur, such as swelling of the face, lips, or throat, or difficulty breathing, immediate medical attention should be sought. Although serious side effects are rare, patients should monitor their reactions to the medication and report any unusual symptoms to their physician. Proper medical supervision can help manage any adverse effects effectively.
Can Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension be used during pregnancy, lactation, and in children?
Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension is considered safe for use during pregnancy and lactation. However, pregnant or breastfeeding women should consult a doctor before using this medication to ensure it is appropriate for their condition. For children and adolescents, Rafcon (500 mg+267 mg+160 mg)/10 ml Suspension should be used only under medical supervision. Since children may have different tolerances and reactions to medications, a healthcare provider’s guidance is essential in determining the correct dosage and ensuring safe administration.